AI-augmented psychotherapy is here

Today’s newsletter is supported by Dragonfruit Ventures.

Dragonfruit Ventures is a $10M early-stage fund (pre-seed/seed), backing bold founders. They combine capital with hands-on operating support, giving time back to founders to allow them to execute on what matters most.
Email [email protected] for inquiries and collaborations, or to apply for funding (or request an intro from me, Tzakhi).

Before we start, a word about my choice for today’s startup. It is the first to get featured on Chosen before raising any external capital from professional investors. The reason is that I have another source of conviction in their potential. One of the founders, Yaakov, is a good friend of mine, but more importantly, he is a brilliant founder, whom I’ve seen up close as he grew and then sold his previous startup. So I feel privileged to share his newest venture with you.

And one more notice, which I hope you will enjoy. I changed the settings on our website so that all of our past features are now open to view (for our subscribers).

Feel free to browse our past blog posts and request an intro to any of the startups you want to connect with.

Psychotherapy and coaching practice will be fundamentally AI-augmented within 3-5 years. Today’s startup is an early mover in this space, unlocking a massive, underserved market with an AI copilot that automates therapy notes and elevates clinical workflows, freeing psychotherapists to see more patients and generate new revenue streams.

Company name: MyPraxis

Website: mypraxis.ai

What they do (in a sentence):

MyPraxis provides psychotherapists with an AI notetaker and practice copilot that significantly reduces their workload and improves their efficacy. MyPraxi listens in real time, drafts compliant session notes, and suggests next‑step interventions.

Why now:

• Psychotherapy and coaching practice will be fundamentally AI-augmented within 3-5 years.

• Demand for therapy is soaring while clinician burnout and admin overload are at all‑time highs.

• Regulatory shifts are pushing providers toward outcome and productivity metrics that MyPraxis directly improves.

Team highlights:

• Yaakov Karda, co‑founder & CEO: Serial entrepreneur. Bootstrapped his last SaaS startup, Chatra, to a 7-digit ARR before it was acquired by Brevo. 

• Max Rozenoer, co-founder and CTO: MIT CS & Math graduate. Co-founder and first CTO of Adotube (acquired by Exponential).

• Stanislav Leo, co-founder and CPO: Practicing psychotherapist + serial tech founder. Built a mental health AI SaaS serving 47,000+ users. 

Traction:

• Completed MVP (first phase). 

Competitive edge:

• Experienced team with strong domain expertise.

Capital raised: None to date (bootstrapped).

Contact:
For investment or business inquiries, contact Yaakov Karda (CEO) or request an introduction by replying to this email.

Last week, 80% of all votes saw Curespec as having a lot of potential.

What do you think about MyPraxis?

***

That’s all for today.

Yours,

Tzakhi and the Chosen.Ventures team

PS Let’s connect:

1. If you invest or are looking to invest in Israeli startups, let’s talk. Reply to this email or go ahead and book a time with me on my Calendly. Thanks.

2. If you are in touch with Israeli startups you believe we should feature, let them know about us or introduce them to me. They can also apply here (there is no cost to getting featured).

3. If you would like to partner, sponsor, or collaborate with us in any way, send me a message by replying to this email.

* Disclaimer: The information we share in our emails and on our website is solely for entertainment purposes and should never be considered investment or financial advice. The startups we feature provide us with the information we share about them, and they are solely responsible for its accuracy. The startups we feature may have business and other connections with us or our affiliates.